Ignite Creation Date:
2024-05-06 @ 3:44 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02364778
Status:
COMPLETED
Last Update Posted:
2016-07-07
First Post:
2015-02-10
Brief Title:
Single-centre Registry Trial the Patients Presented With Stable Coronary Artery Disease
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Study Overview
Official Title:
ORBID Trial Three-Dimensional 3D Optical Coherence Tomography Guided Assessment of Side Branch Vessel After Provisional Main Vessel Stenting in Coronary Artery Stenting
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective study to analyze the outcome of provisional main vessel stenting on side branch by utilizing Two-Dimensional 2D and Three-Dimensional 3D frequency domain optical coherence tomography FD-OCT To analyze the fate of side-branch after provisional main vessel stenting based on morphology defined prior to PCI by OCT Offline analysis of side branch impingement of the ostium of SB leading to acute loss in SB diameter area carina shift and plaque shift will be also be performed
Detailed Description:
Patients with stable coronary artery disease with angiographic main vessel lesion not involving side branch SB in whom provisional stenting strategy is planned will be recruited All the participants of the registry will receive same stent OCT will be performed to analyze plaque morphology SB size SB angle and side branch ostial involvement
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None